Page 14 | Certara

Publication

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

The paper reviews current applications of pediatric PBPK across therapeutic areas and outlines where PBPK…

CertaraNovember 21, 2025

Poster

Early Systematic PICO Scenario Identification and Prioritization for EU HTA Joint Clinical Assessments

Discover a systematic, AI-enabled approach to early PICO scenario identification and prioritization to improve EU…

CertaraNovember 20, 2025

Conference

2025 MFDS-KCDA Annual Conference

CertaraNovember 20, 2025

Conference

PHUSE APAC Connect 2026

–

CertaraNovember 20, 2025

Guide

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…

CertaraNovember 17, 2025

Blog

From Insight to Impact: Certainty EMEA 2025

See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…

CertaraNovember 17, 2025

Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.

CertaraNovember 14, 2025

On-Demand Webinar

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

Explore how Certara’s CoAuthor™ streamlines medical writing using generative AI, reducing repetitive tasks and improving…

CertaraNovember 14, 2025

Blog

Using M&S to Evaluate Oncology Drug Dosing

Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…

CertaraNovember 14, 2025

Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

CertaraNovember 13, 2025

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

Early Systematic PICO Scenario Identification and Prioritization for EU HTA Joint Clinical Assessments

2025 MFDS-KCDA Annual Conference

PHUSE APAC Connect 2026

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

From Insight to Impact: Certainty EMEA 2025

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

Using M&S to Evaluate Oncology Drug Dosing

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Newsletter sign up

Quick links

Solutions

Contact